Accurate and timely infection diagnosis is essential for effective treatment, infection control, and antimicrobial stewardship. Delays in identifying the underlying cause of an infection can lead to complications, prolonged illness, and unnecessary or ineffective antibiotic use.
Proteus Genomics Labs developed the PRO Panel suite to address these challenges. Built on polymerase chain reaction (PCR) technology, each panel rapidly detects specific pathogens and resistance markers with high sensitivity and specificity. The result is a diagnostic approach that provides clinicians with the clarity they need—often within hours instead of days.
Every patient interaction, from a routine checkup to a complex diagnosis, often begins with these essential tests. They inform everything from medication adjustments to chronic disease management and pre-surgical evaluations.
What Are the PRO Panels?
- The PRO Panels are a collection of focused molecular tests designed to identify pathogens in key infection categories. Each panel is tailored to a specific clinical need, offering comprehensive detection across a range of organisms:
- Respiratory-PRO: Detects bacterial and viral pathogens that cause respiratory infections such as pneumonia, influenza, RSV, and COVID-19.
- UTI-PRO: Identifies bacterial and fungal organisms responsible for urinary tract infections and includes resistance gene detection to guide antibiotic selection.
- STI-PRO: Screens for common sexually transmitted infections including Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium.
- Women’s Health PRO: Evaluates pathogens and imbalances that affect gynecologic and reproductive health, such as bacterial vaginosis organisms and Candida species.
- Wound-PRO: Detects bacteria and fungi present in wound and surgical site infections, including Staphylococcus aureus and Pseudomonas aeruginosa.
Advantages of Molecular-Based Testing
Traditional culture methods have long been the standard for infection diagnosis, but molecular testing offers several important advantages:
Speed: PCR can deliver results within 24–48 hours, enabling earlier intervention and reducing unnecessary broad-spectrum antibiotic use.
Sensitivity: Detects pathogens that may be missed by culture, particularly in patients already on antibiotic therapy.
Comprehensiveness: Identifies multiple organisms and resistance genes in a single test.
Actionable Data: Reports are structured for clarity, helping providers interpret results quickly and select targeted treatments.
By integrating molecular testing into clinical workflows, providers gain a faster, more accurate way to confirm infection and guide care decisions.
Integrating PRO Panels Into Everyday Practice
Molecular diagnostics are no longer reserved for specialty centers. As PRO Panels become more accessible, clinics, urgent care centers, and hospitals can now offer precise infectious disease testing as part of routine care.
Providers who partner with Proteus gain access to reliable, high-quality diagnostics that streamline operations, reduce unnecessary antibiotic use, and support value-based healthcare goals.
Infectious disease testing is evolving—and the PRO Panels represent the next step forward. By combining molecular precision with rapid turnaround and expert laboratory support, Proteus Genomics Labs empowers providers to diagnose confidently, treat effectively, and improve patient outcomes.
